Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on theAudited Financial Results (Standalone and Consolidated) for the quarter and the financial yearended 31st March, 2026.
Press Release May 04 2026
Filed with NSE · · 8 pages · English
Release
Earlier from Wockhardt
- Press Release Mar 30 2026
- Press Release Feb 10 2026
- Press Release Jan 27 2026
- Press Release Jan 07 2026
- Press Release Dec 31 2025
Later from Wockhardt
- Press Release May 28 2026
- Press Release May 30 2026
- Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
- Wockhardt Limited Press Release Aug 10 2026
- Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.".
Follow Wockhardt into a list and get an email when it puts out news.
Follow Wockhardt